
Eurofins Scientific is an international life sciences company providing a unique range of analytical testing services across multiple industries. Our work supports safer food, clean water, effective pharmaceuticals, and a healthier, more sustainable environment. With a global presence and a commitment to scientific excellence, Eurofins partners with many of the world’s leading companies to ensure product safety, quality, and compliance.
Eurofins USA PSS Insourcing Solutions is seeking a Scientist – Biocatalysis & Enzymatic Process Development to support a client‑based research program in applied biocatalysis. In this role, you will leverage enzymatic transformations to prepare chiral intermediates and optimize reaction conditions that accelerate chemical and process development.
The successful candidate will take ownership of research projects under the guidance of subject matter experts, contribute to method and process optimization, and generate high‑quality scientific documentation while adhering to laboratory safety and compliance standards.
Key Responsibilities
Minimum Qualifications
Preferred Qualifications
Position is Full Time, Monday – Friday, First Shift. Candidates currently living within a commutable distance of Cambridge, MA, are encouraged to apply. Excellent full-time benefits, including comprehensive medical coverage, dental, and vision options.
If you are passionate about enzymatic chemistry, chiral synthesis, and advancing biocatalytic processes, we invite you to apply and become part of a team shaping the future of sustainable and efficient chemical development.
Eurofins USA PSS Insourcing Solutions is a Disabled and Veteran Equal Employment Opportunity employer.

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories.
Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.